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Abstract
Background: Recent understanding that insulin resistance is an inflammatory condition necessitates searching for genes
that regulate inflammation in insulin sensitive tissues. 12/15-lipoxygenase (12/15LO) regulates the expression of
proinflammatory cytokines and chemokines and is implicated in the early development of diet-induced atherosclerosis.
Thus, we tested the hypothesis that 12/15LO is involved in the onset of high fat diet (HFD)-induced insulin resistance.
Methodology/Principal Findings: Cells over-expressing 12/15LO secreted two potent chemokines, MCP-1 and osteopontin,
implicated in the development of insulin resistance. We assessed adipose tissue inflammation and whole body insulin
resistance in wild type (WT) and 12/15LO knockout (KO) mice after 2–4 weeks on HFD. In adipose tissue from WT mice, HFD
resulted in recruitment of CD11b
+, F4/80
+ macrophages and elevated protein levels of the inflammatory markers IL-1b, IL-6,
IL-10, IL-12, IFNc, Cxcl1 and TNFa. Remarkably, adipose tissue from HFD-fed 12/15LO KO mice was not infiltrated by
macrophages and did not display any increase in the inflammatory markers compared to adipose tissue from normal chow-
fed mice. WT mice developed severe whole body (hepatic and skeletal muscle) insulin resistance after HFD, as measured by
hyperinsulinemic euglycemic clamp. In contrast, 12/15LO KO mice exhibited no HFD-induced change in insulin-stimulated
glucose disposal rate or hepatic glucose output during clamp studies. Insulin-stimulated Akt phosphorylation in muscle
tissue from HFD-fed mice was significantly greater in 12/15LO KO mice than in WT mice.
Conclusions: These results demonstrate that 12/15LO mediates early stages of adipose tissue inflammation and whole body
insulin resistance induced by high fat feeding.
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Introduction
Insulin resistance is a pathophysiological condition associated
with obesity, aging, and type 2 diabetes that affects skeletal muscle,
liver, adipose tissue, and immune cells. Obesity and insulin
resistance are associated with macrophage infiltration and
inflammation in the adipose tissue of humans and rodent models
where a feed-forward cycle of reciprocal adipocyte and macro-
phage activation results in the secretion of inflammatory proteins
and further macrophage recruitment [1,2]. Pro-inflammatory
factors secreted by macrophages and adipocytes are elevated in
adipose tissue from obese and type 2 diabetic patients [3]. Adipose
tissue inflammation induces insulin resistance through inactivation
of insulin receptor substrates (IRS) by cytokine-activated JNK,
IKKb and SOCS [1]. High fat diet (HFD) feeding, a commonly
studied model of insulin resistance in rodents, rapidly causes
progressive metabolic maladies [4,5]. Insulin resistance in heart,
adipose tissue, liver, and muscle, adipose tissue hypertrophy and
inflammatory cell infiltration, and hyperinsulinemia are signifi-
cantly robust phenotypes observed as early as 1–3 weeks of HFD,
with minimal to no total body weight gain [4,6–8]. After 16–20
weeks of HFD, these phenotypes are much more pronounced and
additional severe metabolic dysregulations are present including
dyslipidemia & ectopic triglyceride storage, hypo-adiponectinemia,
adipose tissue hypoxia, cell death and remodeling, beta-cell
decompensation, mild hyperglycemia, and deterioration of cardiac
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induced adipose tissue inflammation and macrophage infiltration
are not well characterized. Recent studies suggest an important
role for 12/15-lipoxygenase (12/15LO) in monocyte recruitment
to and regulation of inflammation in vascular and adipose tissue.
The family of 12/15LO enzymes catalyzes the insertion of
molecular oxygen in arachidonic acid (20:4) at the 12
th and/or 15
th
carbon, resulting in a fatty acid hydroperoxide. 12/15LO
oxygenates linoleic acid (18:2) at the 9
th and/or 13
th carbon. Free
unsaturated fatty acids as well as fatty acids esterified in
phospholipids and cholesteryl esters are substrates for 12/15LO.
The 12/15LO enzymes are conserved among many plant and
animal species and include soybean 15LO, human 15LO (Entrez
Gene ID 246), and mouse 12/15LO (Entrez Gene ID 11687). In
mammals, 12/15LO is expressed in differentiated macrophages,
dendritic cells, inflamed endothelial and smooth muscle cells, and in
certain tumors [9–14]. There is an emerging understanding that, in
both plants and mammals, 12/15LO products are involved in the
signaling processes of defense response and inflammation. In plants,
12/15LO initiates the synthesis of jasmonic acid, which regulates
defensive genes that respond to wound- and insect-inflicted damage
[15,16]. In mammalian cells, 12/15LO products regulate small
GTPases Ras and RhoA, MAP kinases, PKC, and transcription
factor NF-kB [12,17]. Our previous studies suggest that 12/15LO
oxidation products activate toll-like receptor-4 (TLR4) in macro-
phages [18,19]. Cells that express 12/15LO or are activated with
12/15LO oxidation products produce MCP-1, IL-6, IL-8 and
TNFa and induce monocyte binding to endothelial cells [20–26].
12/15LOhasbeenimplicatedinthedevelopmentofautoimmune
diabetes and in vascular complications of diabetes. Arachidonic acid
stimulates insulin secretion by b-cells and this process is inhibited by
the 12/15LO activity [27]. Moreover, 12/15LO mediates cytokine-
induced b-cell damage [28]. Other data suggest that non-obese
diabetic (NOD) mice congenic for a targeted deletion of 12/15LO
are in fact protected from autoimmune diabetes [29]. A recent study
has shown that long-term (8–24 weeks) high fat feeding induces 12/
15LO activation and beta cell damage in pancreatic islets, both of
which were prevented in 12/15LO KO mice [30]. 12/15LO is also
involved in vascular complications of advanced diabetes, such as
atherosclerosis and nephropathy, which manifest life-threatening
conditions. Specifically under diabetic conditions, vascular smooth
muscle cells (VSMC) express 12/15LO which in turn mediates a
VSMC switch from a contractile phenotype to a migratory and
inflammatory phenotype [9,22,31,32]. This change together with
12/15LO-mediatedlipoproteinoxidationandmonocyteadhesionto
endothelial cells explains the involvement of 12/15LO in the
pathogenesis of high fat diet (HFD)-induced atherosclerosis [33–36].
Although these previous studies show that 12/15LO plays a role
in regulating b-cell survival, advanced diabetic complications and,
in a very recent publication, chronic (8–24 weeks) HFD-induced
insulin resistance and inflammation [30], the possible involvement
of 12/15LO in the early development of insulin resistance has not
been studied. Given that 12/15LO is an inflammatory modulator,
we asked whether it is required for the onset of HFD-induced
insulin resistance. We found that 12/15LO deficiency protected
mice from exhibiting elevated inflammatory markers in adipose
tissue and, remarkably, prevented whole-body insulin resistance
induced by 2–4 weeks of high fat feeding.
Methods
Cells
Murine fibroblast cell lines stably over-expressing human 15LO
or b-galactosidase (LacZ) [37,38] were cultured in 10% FBS/
DMEM/gentamicin with 0.5 mg/ml G418 (Calbiochem, San
Diego, CA) to maintain selection.
Animals
Male C57BL6 wild type mice were from Jackson Laboratories.
Male 12/15LO knockout mice, backcrossed in a C57BL6
background for 10 generations, were a generous gift from Dr.
Colin Funk (Queen’s University). Starting 16 weeks of age, mice
were fed either normal chow (12% kcal from fat; Purina 5001 Lab
Diet) of high fat diet (41% kcal from fat; TD96132, Harlan
Teklad) for 2 or 4 weeks. All mice involved in clamp studies (wild
type and 12/15LO KO, n=20 each) were singly housed during
the two weeks of dietary intervention. This was done in order to
ensure equal food access, protect the implanted catheters, and
prevent fighting between mice. Mice used for other experiments
(acute insulin and adipose tissue FACS studies, n=20 per strain)
were housed 1–3 in a cage. There were infrequent circumstances
(,5 mice total in these studies) when a non-clamp study mouse
was singly-housed (for example, an aggressor had to be separated
from cage mates to prevent stress and injury to the other mice and
to ensure access to food. Mice were housed under controlled light
(12:12 light:dark) and climate conditions with unlimited access to
food and water. All procedures were performed in accordance
with the Guide for Care and Use of Laboratory Animals of the National
Institutes of Health and were approved by the University of
California, San Diego, Animal Subjects Committee.
Analytical methods
Total RNA was isolated from cell lysates using an RNeasy kit
from Quiagen (Valencia, CA). Quantitative RT-PCR was
performed to measure MCP-1, OPN and GAPDH mRNA levels
using a Rotor-Gene RG3000 qPCR machine (Corbett Research,
Brisbane, Australia). Primers and probes were from Applied
Biosystems (Foster City, CA). The protein levels of MCP-1 in
conditioned media were measured by ELISA using a kit from
R&D Systems (Minneapolis, MN). The protein levels of OPN in
conditioned media were assayed by immunoblot using a primary
antibody from Santa Cruz Biotechnology (Santa Cruz, CA).
In vivo metabolic studies
Insulin sensitivity was assessed in mice fed HFD for 2 weeks using
a sub-maximal hyperinsulinemic euglycemic glucose clamp tech-
nique as previously described (34), with the following modifications:
1) isoflurane was used for anesthesia during the catheter insertion
surgery three days prior to clamp, 2) glucose tracer was infused at
2 mCi/hr during the clamp, and 3) insulin was infused at 3 mU/kg/
min during the clamp. The mice were conscious during the clamp
and fully recovered after the procedure. Four days later, the mice
were fasted for 5 hr, anesthetized (isoflurane) to collect blood by
cardiac puncture, and then euthanized (pentobarbital) to collect
gastrocnemius muscle, liver, and epididymal adipose tissues.
Excised tissues were flash-frozen in liquid nitrogen. Plasma glucose
specific activity, glucose disposal rate (GDR), and hepatic glucose
output (HGO) were calculated as previously described [39]. In a
separate group of mice, acute insulin stimulation was achieved by
intraperitoneal injection of 6 hr-fasted mice with 0.85 U/kg insulin.
After 15 min, the mice were sacrificed and muscle was harvested as
described above.
Fluorescence-activated cell sorting (FACS) of adipose
tissue SVCs
Adipose tissue stromal vascular cells (SVCs) were isolated and
analyzed by FACS as previously reported [6] with minor
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separately rinsed and minced in DPBS +1% BSA and then treated
with 1 mg/mL type II collagenase (Sigma, St. Louis, MO) for
25 min in a 37uC shaking water bath. Adipose tissue cell
suspensions were filtered through a 100 mm mesh. SVCs were
separated from floating adipocytes by centrifugation, incubated in
RBC lysis buffer (eBioscience, San Diego, CA) for 5 min, and re-
suspended in fresh DPBS +1% BSA. SVCs were incubated with Fc
Block (BD Biosciences, San Jose, CA) for 15 min and then stained
for 30 min with fluorescent-conjugated antibodies against F4/80
(Ab Serotec, Raleigh, NC) and CD11b (BD Biosciences). Cells
were washed two times and re-suspended in DPBS +1% BSA and
propidium iodide (Sigma). Presence of the fluorescent stains in the
SVCs was analyzed using a FACS Calibur flow cytometer (BD
Biosciences). Control SVCs preparations included unstained cells,
PI-only stained cells, and fluorescence-minus-one (FMO) stained
cells and were used to set gatings and compensation.
Plasma and tissue analyses
Plasma insulin levels were measured using the Insulin
Ultrasensitive (Mouse) EIA method (Alpco, Salem, NH). Muscle
lysates were analyzed by western blotting with antibodies against
total Akt and phospho-serine Akt (Cell Signaling, Danvers, MA).
Signal intensities on chemiluminescence-exposed autoradiographs
were densitometrically quantified using a digital Kodak 3D Image
station and associated digital image analysis software (Kodak, New
Haven, CT). The protein levels of IL-1b, IL-12p70, IFNc, IL-6,
IL-10, Cxcl1 and TNFa in adipose tissue lysates were measured
using a multiplex (7-plex) ELISA (Meso Scale Discovery,
Gaithersburg, MD).
Statistical analyses
Student’s t-test and ANOVA (and Tukey’s post hoc test) were
applied for statistical analyses. A p-value cutoff of 0.05 was used to
determine statistical significance.
Results
12/15LO expression increases chemokine production
Expression of 12/15LO in various smooth muscle cells and
macrophages induces the expression of proinflammatory genes
[21,22,24,26]. We used fibroblast cell lines that stably express
human 15LO or LacZ (as a negative control) [37] to test whether
our 15LO-expressing cells (15LO cells) produce excess pro-
inflammatory proteins compared to LacZ-expressing control cells
(LacZ cells). We focused on chemokines that could attract
monocytes to adipose tissue and have been shown to be involved
in the pathogenesis of insulin resistance. Monocyte chemoattrac-
tant protein-1 (MCP-1) contributes to macrophage infiltration in
adipose tissue and insulin resistance [40,41]. Osteopontin (OPN) is
a proinflammatory cytokine and monocyte chemotactic factor that
also mediates obesity-induced insulin resistance [42]. We found
that the 15LO cells expressed significantly higher levels of MCP-1
and OPN (mRNA and protein) than the LacZ cells (Figure 1).
Expression of other inflammatory mediators TNFa, MIP-2, MIP-
1a and IkBf was not different between the 15LO and LacZ cells
(not shown).
HFD-induced inflammation in adipose tissue is absent in
12/15LO KO mice
Because 12/15LO regulates the expression of monocytic
chemokines (Figure 1 and refs. [21,22,24]), we compared the
effects of short-term high fat feeding on adipose tissue inflamma-
tion in C57BL6 wild type (WT) and strain-, gender-, and age-
matched 12/15LO knockout (KO) mice. We assessed adipose
tissue macrophage infiltration in isolated epididymal white adipose
tissue-derived stromal vascular cells (SVCs) using fluorescence-
activated cell sorting (FACS), which is a more sensitive and
comprehensive method compared to immuno-histochemistry.
Because macrophages expressing F4/80 and/or CD11b are
increased in adipose tissue after HFD [5,40,43], we measured
the percentage of live SVCs that express F4/80 or CD11b and the
percentage of live SVCs that express both F4/80 and CD11b. The
percentage of adipose tissue-derived SVCs expressing F4/80 and/
or CD11b was significantly increased in WT mice fed HFD for
two weeks (Figure 2) compared to WT mice fed normal chow
(NC). This trend of increased macrophage presence also existed
after four weeks of HFD. In contrast, adipose tissue-derived SVCs
isolated from 12/15LO KO mice fed HFD for four weeks
exhibited no change in the percentage of cells expressing F4/80
and CD11b compared with NC-fed 12/15LO KO mice.
We next measured cytokine protein levels in epididymal white
adipose tissue (eWAT) lysates from WT and 12/15LO KO mice
fed NC or HFD for two weeks. We observed significantly elevated
levels of IL-1b, IL-12p70, IFNc, IL-6, and IL-10 in eWAT lysates
from HFD-fed WT mice compared to NC-fed WT mice (Figure 3).
Cxcl1 (KC) and TNFa levels also tended to increase after HFD in
WT mice but this increase did not reach statistical significance.
None of these cytokines were elevated in the plasma of WT mice
Figure 1. Proinflammatory chemokine production by 15LO-
expressing cells. A. Fold difference in OPN and MCP-1 mRNA
expression in murine fibroblasts constitutively expressing human 15LO
or LacZ. OPN and MCP-1 mRNA levels were measured by qPCR of total
RNA and were normalized to GAPDH mRNA. B. Levels of MCP-1 protein
in conditioned media from 15LO and LacZ cells, as assayed by ELISA. C.
Autoradiograph of OPN protein in conditioned media from 15LO and
LacZ cells, as determined by western blotting.
doi:10.1371/journal.pone.0007250.g001
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mice, 12/15LO KO mice were completely protected from HFD-
induced increases in IL-1b, IL-12p70, IFNc, IL-6, IL-10, Cxcl1
and TNFa levels in eWAT. The absence of HFD-induced
cytokine elevation in the adipose tissue of 12/15LO KO mice
(Figure 3) corresponds with the absence of HFD-induced
macrophage infiltration in the adipose tissue of these mice
(Figure 2) and supports the notion that, in contrast to WT mice,
12/15LO KO mice fed HFD for two to four weeks do not exhibit
macrophage-mediated, adipose tissue inflammation.
12/15LO KO mice are protected from HFD-induced
insulin resistance
We investigated whether the absence of HFD-induced adipose
tissue inflammation in 12/15LO KO mice correlated with
protection from whole body insulin resistance. We conducted
euglycemic hyperinsulinemic clamp studies on WT and 12/
15LO KO mice fed NC or HFD for two weeks. High fat feeding
induced significant differences in clamp data from HFD-fed
compared to NC-fed WT mice, specifically, 76% lower glucose
infusion rate (Ginf), 60% lower glucose disposal rate (GDR), and
76% higher hepatic glucose output rate (HGO) (Figure 4A–C).
12/15LO KO mice were completely protected from the severe
HFD-induced changes in Ginf, GDR, and HGO that we
observed in WT mice. There was no significant difference in
basal glucose turnover rate (basal HGO=basal GDR) between
t h eN C - f e dW T( 1 5 . 9 62.2 mg/kg/min) and 12/15LO KO mice
(16.061.9 mg/kg/min) or between the WT NC-fed and WT
HFD-fed mice (15.761.9 mg/kg/min). The clamp study data
indicate that 12/15LO deficiency provides protection from
HFD-induced hepatic and skeletal muscle insulin resistance.
HFD-fed 12/15LO KO mice did exhibit a similar fold increase
in eWAT mass but not hyperinsulinemia, compared to HFD-fed
WT mice (Table 1). To demonstrate that there was no direct
dependency between adiposity and insulin resistance in WT and
12/15LO KO mice, we normalized the GDR values to the fat
p a dm a s sa sa%o fb o d yw e i g h t .F i g u r e4 Ds h o w st h a t ,e v e na f t e r
this normalization, there remains a dramatically different insulin
sensitivity between WT and 12/15LO KO mice fed chow or
high-fat diet.
Diminished insulin-activated Akt phosphorylation in
muscle from HFD-fed WT compared to 12/15LO KO mice
In order to assess the effects of 12/15LO KO on insulin signal
transduction in skeletal muscle from mice fed HFD, we examined
acute insulin-activated Akt phosphorylation in a separate group of
mice. Serine-phosphorylation of Akt in muscle lysates (phospho-
Ser
473 Akt normalized to total Akt protein) was determined by
western blot using primary antibodies for total Akt protein and
phospho-Ser
473 Akt. As expected, acute insulin treatment induced
phosphorylation of Akt in both groups (Figure 5). However, the
absolute level of insulin-stimulated Akt phosphorylation and the
insulin-stimulated fold change in Akt phosphorylation were both
significantly greater, two- and three-fold, respectively, in 12/15LO
KO mice compared to WT mice. Because activation (phosphor-
ylation) of Akt is a critical early event in the insulin receptor
signaling, these data corroborate our in vivo results (Figure 4B)
demonstrating greater insulin sensitivity in the muscle of HFD-fed
12/15LO KO mice compared to WT mice.
Discussion
HFD-induced and obesity-related insulin resistance is associated
with chronic low grade inflammation in adipose tissue character-
ized by macrophage infiltration and elevation of inflammatory
cytokine expression. HFD-induced effects on adipose tissue
inflammation are initiated early in the course of high fat feeding
and are coincident with insulin resistance [5,6]. Although the
known biological roles of 12/15LO include regulating inflamma-
tion, a role for 12/15LO in the early development of HFD-
induced adipose tissue inflammation and/or whole body insulin
resistance has not been described. 12/15LO is expressed in all
vascular cell types, including endothelial cells, macrophages and
VSMCs, and its expression is elevated under inflammatory
conditions. Therefore, we hypothesized that 12/15LO might
regulate HFD-induced adipose tissue inflammation. Indeed, we
found that high fat feeding induced macrophage infiltration into
adipose tissue of WT but not 12/15LO KO mice, presumably, via
12/15LO-regulated chemokine secretion. The difference in
adipose tissue macrophage infiltration between HFD-fed WT
and 12/15LO KO mice corresponded with their difference in
Figure 2. FACS analysis of macrophage content in adipose tissue SVCs. A. HFD-induced fold change in the percent of live adipose tissue
SVCs expressing surface markers F4/80, CD11b, and both F4/80 and CD11b. SVCs were isolated from eWAT of mice fed NC, two-week HFD, or four-
week HFD. *p,0.05 vs WT NC,ˆp,0.05 vs WT two-week HFD,
$p,0.05 vs WT four-week HFD.
doi:10.1371/journal.pone.0007250.g002
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PLoS ONE | www.plosone.org 4 September 2009 | Volume 4 | Issue 9 | e7250Figure 3. Adipose tissue cytokine levels. Cytokine protein levels measured in eWAT lysates from WT (black bars) and 12/15LO KO (gray bars)
mice fed NC or two-week HFD. Values are mean6standard error. 8–10 animals per group. *p,0.05 vs diet-matched WT,
#p,0.05 vs strain-matched
NC.
doi:10.1371/journal.pone.0007250.g003
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being protected from adipose tissue inflammation, HFD-fed 12/
15LO KO mice were also dramatically protected from hepatic
and skeletal muscle insulin resistance compared to HFD-fed WT
mice.
Adipose tissue macrophages are derived from circulating
monocytes that attach to and migrate through endothelial cells
(ECs) in the tissue microvasculature. 12/15LO expression and
activity is increased in atherogenic and hyperglycemic diabetes
models [12,36,44,45], conditions similar to the postprandial state
of non-diabetic, diet-induced insulin resistance in which case
hyperlipidemia and hyperglycemia are more pronounced and
sustained. In these model conditions, activated 12/15LO regulates
monocyte attachment to ECs in part by increasing expression
of adhesion molecule ICAM-1 on the surface of ECs via activation
of RhoA and NF-kB [12,36]. 12/15LO increases the expression of
chemokines MCP-1 and OPN (our data presented here and
[21,24,26]). Thus, 12/15LO-mediated regulation of chemoattrac-
tants and an adhesion receptor may account for the increased
monocyte infiltration into adipose tissue that we observed in HFD-
fed WT but not 12/15LO KO mice.
Both WT and 12/15LO KO mice exhibited an approximate
two-fold increase in eWAT mass during the two-week high fat
feeding period. Although HFD-induced eWAT expansion in 12/
15LO KO mice was somewhat blunted compared to WT mice,
the fold change in mass compared to NC-fed controls was
Figure 4. Characterization of whole body insulin sensitivity. Hyperinsulinemic euglycemic clamp studies were conducted to calculate
(A) Ginf, (B) GDR, (C) HGO, and (D) GDR normalized to fat pad mass as a percent of body weight in WT (black bars) and 12/15LO KO (gray bars) mice
fed NC or two-week HFD. Values are mean6standard error. 7–9 animals per group. *p,0.05 vs WT HFD,
#p,0.05 vs WT NC.
doi:10.1371/journal.pone.0007250.g004
Table 1. Mouse strain characteristics.
WT 12/15-LO KO
NC HFD Fold Change NC HFD Fold Change
Whole body weight, g 26.4 (0.5) 31.2 (0.7) # 25.2 (0.9) 25.2 (0.8) *
Epididymal fat pad weight, g 0.32 (0.02) 0.78 (0.06) # 2.45 (0.20) 0.23 (0.01) 0.43 (0.06) #, * 1.89 (0.26), ns vs WT HFD
Epididymal fat pad mass, % body weight 1.20 (0.08) 2.49 (0.19) # 2.07 (0.16) 0.89 (0.04) 1.64 (0.18) #, * 1.84 (0.20), ns vs WT HFD
Fasting plasma glucose, mg/dL 160 (5) 174 (6) 177 (5) 202 (9) #,*
Fasting plasma insulin, ng/mL 0.51 (0.18) 2.28 (0.83) # 0.63 (0.22) 0.57 (0.18) *
Data are averages6standard error. 7–10 mice per group. * p,0.05 vs diet-matched WT, # p,0.05 vs strain-matched NC. ns - not significant.
doi:10.1371/journal.pone.0007250.t001
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similar eWAT expansion, the number of macrophages and levels
of pro-inflammatory cytokines in eWAT from 12/15LO KO mice
were completely unchanged by HFD, and significantly different
from the elevated levels we observed in HFD-fed WT mice. Our
findings suggest that the proinflammatory effects of 12/15LO
expression observed by Nunemaker, et al. after 8 and 24 weeks of
HFD [30] in fact occur significantly earlier during the initial stages
of HFD-induced insulin resistance (2–4 weeks). Chakrabarti, et al.
have recently demonstrated that 12/15LO is up-regulated in
adipose tissue from high fat fed mice and that 12/15LO products
induce inflammation and insulin resistance in 3T3-L1 adipoctyes
[46]. HFD-induced elevation of eWAT cytokine levels could
originate from macrophages, adipocytes, endothelial cells and/or
preadipocytes within adipose tissue. We speculate that pro-
inflammatory macrophages and adipocytes are the most likely
sources of elevated eWAT cytokines in high fat diet-fed WT mice.
We used a two- and four-week high fat feeding protocol because
it significantly induces the phenotypes of insulin resistance and
adipose tissue hypertrophy and inflammation in WT mice without
causing the severe metabolic dysfunctions that manifest after
longer high fat feeding [4–8]. Mouse phenotypes induced by our
high fat feeding protocol were similar to those observed in other
time course studies of HFD-induced adipose tissue inflammation
and insulin resistance [4–6]. Two-week high fat feeding induced
hyperinsulinemia and severe hepatic and skeletal muscle insulin
resistance in WT but not 12/15LO KO mice. 12/15LO KO mice
exhibited significantly greater insulin-stimulated skeletal muscle
Akt phosphorylation after HFD, compared to WT mice,
corresponding to their greater insulin sensitivity. Given the
cross-talk between adipose tissue, liver, and skeletal muscle that
affects insulin sensitivity [1,47], protection from adipose tissue
inflammation in the 12/15LO KO mice may be the primary site
of action leading to protection from whole body insulin resistance.
In summary, we find that 12/15LO is a key modulator of the
onset of high fat diet-induced insulin resistance in liver, muscle and
adipose tissue. We provide evidence that the mechanism by which
the 12/15LO KO mice are protected from the initial stages of
HFD-induced insulin resistance involves suppression of adipose
tissue pro-inflammatory macrophage infiltration and inflammato-
ry cytokine elevation. 12/15LO is a key participant in the
development of diet-induced insulin resistance and, thus, a viable
therapeutic target for the treatment of human insulin resistance
and type 2 diabetes.
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